Cannabis Law Report

MAY 31, 2022

The first path, that of traditional medicine, currently offers patients limited options. The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems.

Clinical Trials

LifeCannMD

FEBRUARY 27, 2024

This shift towards cannabis-based therapies is reshaping the landscape of Crohn’s management, offering new hope and improved quality of life for patients who have long struggled with the disease’s debilitating symptoms. The impact of Medical Marijuana on the quality of life for Crohn’s patients cannot be overstated.

Marijuana

Cannabis Law Report

MAY 29, 2022

Businesses have been recently receiving approval from Health Canada to farm psychedelic mushrooms, make psilocybin and sell the compound to drug-makers, or to doctors to give to patients. The psilocybin mushrooms are headed to clinical trials, drug companies and medical facilities. “I’m

Research and Development

Otherside Farms

APRIL 30, 2019

This was the year that the Endocannabinoid system was officially discovered, named, and put in the books. The study took a group of 24 never-treated SAD patients and gave half of them a 600mg dose of CBD, and the other half a placebo. Around 200 BC, the Greeks were prescribing cannabis as a remedy for toothaches and earaches.

Oil

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.

Clinical Trials

Cannabis Law Report

DECEMBER 9, 2021

MAPS is sponsoring the most advanced psychedelic therapy research in the world: Phase 3 clinical trials of MDMA-assisted therapy for PTSD. “We are proud to support the profound research of these organizations,” continued Mr.

Research and Development

Cannabis Law Report

JANUARY 13, 2020

We are proud of the positive impact this medicine has already had on thousands of patients and believe that this past year provides a compelling foundation for continued success in 2020,” said Justin Gover, GW’s Chief Executive Officer. Execute NHIE clinical program utilizing an intravenous formulation of cannabidiol. Work with U.S.

Pharmaceutical

Sensi Seeds

NOVEMBER 23, 2018

Dr. Peter McGraw, a behavioural scientist, associate professor of marketing and psychology, and co-author of the book ‘The Humor Code’, posits that three conditions must be met for humour to occur. The frontal lobe of the brain, associated with emotional and social responses, shows increased activity as the wave passes.

Blood Pressure

Cannabis Law Report

OCTOBER 29, 2019

He has authored over 100 scientific articles and books on the assessment, nature and treatment of emotional, cognitive and psychological and neuropsychological problems. He has conducted the largest randomised clinical trial of buprenorphine versus methadone, and this study is a pivotal study for the US FDA registration of buprenorphine.

Law

Cannabis Law Report

OCTOBER 12, 2021

Their audacious vision to reimagine traditional pharma efficacy trials promises to rapidly and accurately determine which nutraceuticals and natural molecules actually work for which conditions,” said Diamandis. Radicle Science also announced a new CTO, Sheldon Borkin , PhD, who joined in September 2021. “And

Clinical Trials

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development

Cannabis Law Report

DECEMBER 21, 2021

Genomics test results allow practitioners and patients to set individualized, trackable goals around pharmacogenomics (PGx), cannabis DNA, nutrition DNA, and fitness DNA for personalized health and wellness. With instant screening test results, both patient and physician receive precious time to develop treatment plans.

Research and Development

Project CBD

OCTOBER 26, 2023

I advise my patients to stop using cannabis for 36 to 48 hours prior to chemotherapy and to start again 36 to 48 hours after their session. Phase 2 is the first study level conducted on patients with the disease for which the drug is intended and determines whether it is safe and effective. mg of THC and 30 mg of CBD.

Research and Development

CannaMD

MARCH 8, 2020

In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. population, has an arrhythmia.

Patients

The Cannigma

MARCH 12, 2021

But sometimes one unintended consequence of adult-use legalization is that the market no longer caters to medical patients. So, you have this attempt to legitimize healthcare and to adopt standards, to do things in a more scientific way, and in a more credible way, for patients and for industry. It’s a non-trivial issue.

Legalization

Cannabis Law Report

MAY 29, 2022

Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. Clinical Trials and Human Subject Protections. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects. 20, 2020), [link]. [8]

Research and Development

SMPL

MAY 26, 2020

“There was a strong sense that this was really going to be something, if when people use these strains they have any kind of experience like the mice did in the laboratories,” said Martin Lee, a writer who at the time had been finishing a book about the social history of marijuana for Simon & Schuster. This led to a discovery. “It

CBD

TheAnswerPage

OCTOBER 27, 2021

whose book on medicinal plants was the leading text in pharmacology for many centuries, writes that it causes madness. Although drugs are available for both conditions not all patients are well treated and novel drugs in both conditions are badly needed. The Roman authority on scientific matters, Pliny the Elder (1 st century C.E.),

Clinical Trials

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Harris has written a variety of books that touch on the topics of consciousness, spirituality, and psychedelics. Rick Doblin, Ph.D,

Research and Development

Cannabis Law Report

OCTOBER 17, 2019

It’s big business,” says Jackim, noting that there are 200,000 patients in the state who hold cards allowing them to purchase cannabis for medical purposes. One CBD-containing product, Nabiximols, sold under the brand name Sativex®, has been registered for use in Australia for the treatment of spasticity in multiple sclerosis patients.

Law